Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 8:33 pm Purchase | 2021-12-31 | 13G | Lexicon Pharmaceuticals, Inc. LXRX | BIOTECHNOLOGY VALUE FUND L P | 14,360,000 9.600% | 3,397,000 (+30.99%) | Filing History |
| 2022-02-11 8:19 pm Sale | 2021-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA | BIOTECHNOLOGY VALUE FUND L P | 559 1.000% | -1,787,000 (-99.97%) | Filing History |
| 2022-02-11 7:54 pm Purchase | 2021-12-31 | 13G | Genocea Biosciences, Inc. GNCA | BIOTECHNOLOGY VALUE FUND L P | 5,930,353 9.990% | 644,804 (+12.20%) | Filing History |
| 2022-02-11 7:44 pm Sale | 2021-12-31 | 13G | GRITSTONE BIO INC GRTSQ | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -2,695,418 (Position Closed) | Filing History |
| 2022-02-11 7:41 pm Sale | 2021-12-31 | 13G | Forte Biosciences, Inc. FBRX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -53,770 (Position Closed) | Filing History |
| 2022-02-11 7:33 pm Sale | 2021-12-31 | 13G | Whitehawk Therapeutics Inc WHWK | BIOTECHNOLOGY VALUE FUND L P | 899,392 4.300% | -247,660 (-21.59%) | Filing History |
| 2022-02-11 7:30 pm Sale | 2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | BIOTECHNOLOGY VALUE FUND L P | 1,370,947 3.000% | -1,527,850 (-52.71%) | Filing History |
| 2022-02-11 7:22 pm Sale | 2021-12-31 | 13G | Merus N.V. MRUS | BIOTECHNOLOGY VALUE FUND L P | 4,135,071 9.600% | -925,000 (-18.28%) | Filing History |
| 2022-01-31 5:07 pm Purchase | 2022-01-27 | 13D | Kymera Therapeutics, Inc. KYMR | BIOTECHNOLOGY VALUE FUND L P | 3,586,658 7.000% | 955,996 (+36.34%) | Filing History |
| 2022-01-28 4:35 pm Purchase | 2022-01-20 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 2,326,710 16.900% | 878,690 (+60.68%) | Filing History |
| 2022-01-24 5:23 pm Purchase | 2022-01-13 | 13G | Aclaris Therapeutics, Inc. ACRS | BIOTECHNOLOGY VALUE FUND L P | 3,868,043 6.300% | 3,868,043 (New Position) | Filing History |
| 2022-01-18 5:18 pm Purchase | 2022-01-07 | 13G | Sutro Biopharma, Inc. STRO | BIOTECHNOLOGY VALUE FUND L P | 316,042 6.800% | 130,625 (+70.45%) | Filing History |
| 2022-01-12 5:05 pm Purchase | 2022-01-10 | 13G | Molecular Partners AG MOLN | BIOTECHNOLOGY VALUE FUND L P | 4,526,282 14.100% | 1,425,000 (+45.95%) | Filing History |
| 2022-01-12 5:03 pm Purchase | 2021-12-31 | 13G | Molecular Partners AG MOLN | BIOTECHNOLOGY VALUE FUND L P | 3,101,282 9.700% | 602,381 (+24.11%) | Filing History |
| 2022-01-11 5:13 pm Purchase | 2022-01-07 | 13D | Rain Enhancement Technologies Holdco Inc RAIN | BIOTECHNOLOGY VALUE FUND L P | 3,526,729 18.800% | 580,922 (+19.72%) | Filing History |
| 2022-01-10 5:57 pm Purchase | 2022-01-06 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 1,448,020 10.100% | 13,088 (+0.91%) | Filing History |
| 2022-01-10 5:51 pm Purchase | 2021-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 1,434,932 9.990% | 1,434,932 (New Position) | Filing History |
| 2022-01-10 4:52 pm Purchase | 2022-01-06 | 13G | Verastem, Inc. VSTM | BIOTECHNOLOGY VALUE FUND L P | 1,542,180 10.200% | 120,333 (+8.46%) | Filing History |
| 2022-01-10 4:49 pm Purchase | 2021-12-31 | 13G | Verastem, Inc. VSTM | BIOTECHNOLOGY VALUE FUND L P | 1,421,847 9.400% | 490,097 (+52.60%) | Filing History |
| 2022-01-03 4:34 pm Purchase | 2021-12-21 | 13G | CytomX Therapeutics, Inc. CTMX | BIOTECHNOLOGY VALUE FUND L P | 5,803,700 8.900% | 2,884,229 (+98.79%) | Filing History |